Rhus coriaria L. increases serum apolipoprotein-A1 and high-density lipoprotein cholesterol levels: a double-blind placebo-controlled randomized clinical trial

2018 ◽  
Vol 16 (1) ◽  
pp. 45-50 ◽  
Author(s):  
Zahra Hajmohammadi ◽  
Mojtaba Heydari ◽  
Majid Nimrouzi ◽  
Pouya Faridi ◽  
Mohammad Javad Zibaeenezhad ◽  
...  
Keyword(s):  
Clinical Trial ◽  
High Density Lipoprotein ◽  
Randomized Clinical Trial ◽  
High Density Lipoprotein Cholesterol ◽  
Density Lipoprotein ◽  
Apolipoprotein A1 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cholesterol Levels ◽  
Rhus Coriaria

scholarly journals α-Tocopherol supplements and high-density-lipoprotein–cholesterol levels

1986 ◽  
Vol 55 (1) ◽  
pp. 71-77 ◽  
Author(s):  
John H. Kalbfleisch ◽  
Joseph J. Barboriak ◽  
Barbara A. Else ◽  
C. Vincent Hughes ◽  
Felix E. Tristani
Keyword(s):  
High Density Lipoprotein ◽  
High Density Lipoprotein Cholesterol ◽  
Density Lipoprotein ◽  
High Density ◽  
Lipoprotein Cholesterol ◽  
Short Term ◽  
Double Blind ◽  
Enhancing Effect ◽  
Cholesterol Levels ◽  
Plasma High Density

1. In a randomized, double-blind 6-month study, α-tocopherol (728 mg) or placebo were administered daily to seventy-eight volunteers (forty-nine men, twenty-nine women) to investigate the possible enhancing effect of vitamin E on plasma high-density-lipoprotein-cholesterol (HDL-C) levels. In addition, the available reported values from short-term (4–6 weeks) studies, as well as the 4-week results from the present study, were combined and analysed for factors which may modify the effect of α-tocopherol on HDL-C.2. No consistent effect of α-tocopherol on plasma HDL-C levels was observed either in the combined 4-week values or in the 6-month study. Further analysis of the combined short-term values and 6-month values indicated that, in subjects with low initial HDL-C levels, treatment with α-tocopherol or placebo did not produce significantly different HDL-C changes.

Sign in / Sign up

Export Citation Format

Share Document